Been invested since 2009 and have been waiting for all that time to see the ALLAY get USA FDA cleared. Still waiting! Not sure, but I think this was rejected once before by the FDA due to insufficient data from trial. It seemed like the company then put ALLAY on the back burner and concentrated ($$$) on the ACTIPATCH and RECOVERY RX. Would love to hear from the company management on where this product stands and if this product is still in consideration for USA FDA clearance. Pretty sure it is available for sale in other countries but probably due to lack of funds, not pushed by our company.
Again, would love to see this cleared and on shelves in USA retail, as it would be the ultimate frequently used and return purchase product. IMO we should see a nice spike in stock price if/when this ever happens.
(1)
(0)
BioElectronics Corporation (BIEL) Stock Research Links